09-Aug-2021

Researchers at ETH Zurich have developed a molecule that fluoresces where new tissue is forming in the body. Alongside helping to detect tumours, the molecule could play a significant role in research of wound healing disorders. Collagen is the most abundant protein in the human body. It makes up ...

more

09-Aug-2021

Researchers at ETH have managed to produce nanocrystals made of two different metals using an amalgamation process whereby a liquid metal penetrates a solid one. This new and surprisingly intuitive technique makes it possible to produce a vast array of intermetallic nanocrystals with tailored ...

more

03-Aug-2021

Many scientific experiments require highly precise time measurements with the help of a clearly defined frequency. Now, a new approach allows the direct comparison of frequency measurements in the lab with the atomic clock in Bern, Switzerland. For many scientific experiments, today’s researchers ...

more

"Virtual chemist" finds molecules that have the same effect as a natural substance but are simpler and low-​cost to produce

08-Jul-2021

Artificial intelligence (AI) is able to recognise the biological activity of natural products in a targeted manner, as researchers at ETH Zurich have demonstrated. Moreover, AI helps to find molecules that have the same effect as a natural substance but are easier to manufacture. This opens up ...

more

Frameshifting as possible target for antiviral drug development

19-May-2021

SARS-​CoV-2 is critically dependent on a special mechanism for the production of its proteins. A collaborative team led by a research group at ETH Zurich obtained molecular insights into this process and demonstrated that it can be inhibited by chemical compounds, thereby significantly reducing ...

more

20-Apr-2021

Machine learning methods help to optimise the development of antibody drugs. This leads to active substances with improved properties, also with regard to tolerability in the body. Antibodies are not only produced by our immune cells to fight viruses and other pathogens in the body. For a few ...

more

Such reprogrammed cells could perform medical tasks in our bodies, such as diagnosing diseases or providing treatment

10-Mar-2021

Scientists at ETH Zurich are working to develop information-​processing switching systems in biological cells. Now, for the first time, they have developed an OR switch in human cells that reacts to different signals. Biological cells might one day be equipped with artificial genetic programs ...

more

Good catalytic performance is driven chiefly by processes that occur on the surface of the catalyst – and not electrochemical processes

20-Nov-2020

Splitting water into hydrogen and oxygen is an important chemical reaction, especially considering that the use of hydrogen as an energy source in sustainable mobility in the future. An international research team has now decoded how one of the catalysts used in this reaction works. Hydrogen is a ...

more

Findings will help catalyst research take an important step forward

30-Oct-2020

“Titanium silicalite-1” (TS-1) is not a new catalyst: It has been almost 40 years since its development and the discovery of its ability to convert propylene into propylene oxide, an important basic chemical in the chemical industry. Now, by combining various methods, a team of scientists from ...

more

A starting point for vaccine and drug development

15-Sep-2020

Researchers at ETH Zurich and the University of Bern have discovered a mechanism by which the corona virus manipulates human cells to ensure its own replication. This knowledge will help to develop drugs and vaccines against the corona virus. Like a pirate hijacking a ship, a virus takes control ...

more